Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Stemcell Holdings Cash from Financing (Quarterly): 0.00 for Sept. 30, 2018
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.8732M |
| March 31, 2018 | -0.9229M |
| December 31, 2017 | -0.0437M |
| September 30, 2017 | -0.00 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.0004M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0013M |
| June 30, 2016 | 0.0678M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.147M |
| Perspective Therapeutics Inc | 166.33M |
| Protalix BioTherapeutics Inc | 0.00 |
| Electromed Inc | 0.056M |
| Armata Pharmaceuticals Inc | 34.93M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.8509M |
| Cash from Investing (Quarterly) | -0.1868M |